How it works:
Who it is intended for:
Research and clinical evidence:
Ivermectin is a well-studied antiparasitic medicine. Clinical research has established its effectiveness in conditions such as intestinal strongyloidiasis and onchocerciasis, with additional uses depending on the specific parasitic infection and treatment regimen. It has also been extensively evaluated in clinical practice and has played an important role in onchocerciasis control programs.
Research demonstrates that ivermectin primarily affects the neuromuscular function of susceptible nematodes and certain other parasites. However, its effectiveness and approved uses depend on the particular infection. Ivermectin should not be considered a universal treatment for all parasites or viral infections.
Ivermectin is used to treat certain parasitic infections. Oral ivermectin is specifically used for intestinal strongyloidiasis and onchocerciasis. In some circumstances, it may be prescribed for other parasitic conditions according to medical guidance.
The medicine acts on the neuromuscular system of susceptible parasites, causing paralysis. The appropriate regimen depends on the diagnosis, body weight, age, and other individual factors.
The tablets are taken orally with water. The dose and treatment schedule depend on the type of parasitic infection and the patient's body weight and should therefore be determined by a healthcare professional. Do not increase the dose without medical advice. Depending on the infection, repeat treatment or laboratory follow-up may be required to assess treatment effectiveness.
Adverse effects
Severe allergic reactions, significant dizziness, altered consciousness, or other serious symptoms require prompt medical attention.
